Gemina Laboratories Ltd.

Biotechnology • Healthcare • Burnaby, BC, United States • GLABF (PNK)

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It also develops respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada.

3600 Gilmore Way, Burnaby, BC V5G 4W8, Canada

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Gemina Laboratories Announces Termination of Transaction - Yahoo Finance

Yahoo Finance • Oct 1

Check out Gemina Laboratories Ltd's stock price (GLABF) in real time - CNBC

CNBC • Feb 17

Crypto exchange Gemini prices IPO above range to raise $425 million - Yahoo! Finance Canada

Yahoo! Finance Canada • Sep 11

How to create 3D model of yourself with Gemini Nano Banana AI? Check our step-by-step guide - livemint.com

livemint.com • Sep 12

Newly Merged Amneal Pharmaceuticals to Push into the Biosimilar Space - BioSpace

BioSpace • May 10

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Gemina Laboratories Ltd. had layoffs?

No layoff events have been recorded for Gemina Laboratories Ltd. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is Gemina Laboratories Ltd. in?

Gemina Laboratories Ltd. operates in the Biotechnology industry, within the Healthcare sector.

Is Gemina Laboratories Ltd. a publicly traded company?

Yes, Gemina Laboratories Ltd. is publicly traded under the ticker symbol GLABF on the PNK. The company has a market capitalization of approximately $0.00 billion.

Where is Gemina Laboratories Ltd. headquartered?

Gemina Laboratories Ltd. is headquartered in Burnaby, BC, United States at 3600 Gilmore Way, Burnaby, BC V5G 4W8, Canada.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.